Sign In
Buy COR
$311.34
-0.89 (-0.285%)
At Close: Jul 31, 2026
Countdown to Cencora (COR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
10:16am, Friday, 31'st Jul 2026
Beyond analysts' top-and-bottom-line estimates for Cencora (COR), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter e
2,060 Shares in Cencora, Inc. $COR Acquired by BankChampaign National Association
04:03am, Friday, 31'st Jul 2026
BankChampaign National Association acquired a new stake in Cencora, Inc. (NYSE: COR) during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)
Cencora (COR) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:01am, Wednesday, 29'th Jul 2026
Cencora (COR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Delta Global Management LP Makes New $1.44 Million Investment in Cencora, Inc. $COR
04:43am, Monday, 27'th Jul 2026
Delta Global Management LP bought a new stake in shares of Cencora, Inc. (NYSE: COR) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund
Bank of Nova Scotia Boosts Stock Holdings in Cencora, Inc. $COR
04:05am, Saturday, 25'th Jul 2026
Bank of Nova Scotia grew its stake in shares of Cencora, Inc. (NYSE: COR) by 7.7% during the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange
Here's Why You Should Add Cencora Stock to Your Portfolio Now
12:11pm, Friday, 24'th Jul 2026
COR's specialty expansion, supply-chain investments and international momentum support growth, though pricing, debt and regulation pose risks.
Bet on 5 Top-Ranked Stocks With Rising P/E
09:25am, Thursday, 23'rd Jul 2026
Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach.
Cencora: Specialty Infrastructure Is Rewriting The Distributor Model
01:41pm, Wednesday, 22'nd Jul 2026
Cencora (COR) is transitioning from a bulk pharmaceutical distributor to a specialty medicines infrastructure provider, targeting higher-margin, service-driven growth. Recent acquisitions of OneOncolo
Is Cencora Inc (COR) Overvalued After 3.9% Rally? GF Value Says Overvalued
05:49pm, Thursday, 16'th Jul 2026
On July 16, 2026, Cencora Inc (COR) shares rose 3.9% to a current price of $307.99. This price performance is notable as it sits within a 52-week range of $244.
Artisan Mid Cap Fund Q2 2026 Performance Review
01:56pm, Wednesday, 15'th Jul 2026
Artisan Mid Cap Fund portfolio generated strong absolute returns and outpaced the Russell Midcap® Growth Index. Within IT, several semiconductor holdings produced exceptional returns, with multiple p
Carillon Eagle Mid Cap Growth Fund Q2 2026 Portfolio Review
08:53am, Tuesday, 14'th Jul 2026
Carillon Eagle Mid Cap Growth Fund stocks delivered solid results in the second quarter. Top securities in the quarter were Datadog, Marvell, Vertiv, Teradyne and Macom Technology Solutions. Top secur
Eli Lilly and vs. Teva: Which Pharmaceutical Stock Is a Better Buy in 2026?
01:09pm, Monday, 06'th Jul 2026
Growth premium vs. value recovery, one trades at 33x forward earnings while the other navigates debt reduction and biosimilar expansion.
Cencora Announces Date and Time for Third Quarter Fiscal 2026 Earnings Release
04:30pm, Wednesday, 01'st Jul 2026
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) today announced that it plans to release its results for the Third Quarter of Fiscal 2026 on Wednesday, August 5, 2026, prior to the openi
COR Stock Down Nearly 18% YTD: Should You Buy, Hold or Sell?
01:50pm, Thursday, 18'th Jun 2026
COR shares are down 18% YTD, but rising EPS guidance, specialty pharma growth and strategic expansion could make this pullback worth watching.
Cencora Launches Enhanced Nucleus Solution for Specialty Practices
11:36am, Thursday, 18'th Jun 2026
COR's enhanced Nucleus platform targets complex specialty medication workflows, with a pilot underway across more than 20 physician practice sites.
